Microbot Medical, Inc (MBOT): רווח למניה בשנים עשר החודשים האחרונים

Microbot Medical Inc. leverages Israeli and American capacities to develop disposable microsurgery systems. The company is currently deploying automated assembly lines and testing AI algorithms for microcatheters. The robotization of endovascular procedures creates a long-term dependence of clinics on high-cost consumables. The trailing 12-month daily EPS indicator from the GURU.Markets service reflects the current status of -0.26.

This indicator measures the portion of net income attributable to a single common share, allowing for an assessment of the real efficiency of capital generation regardless of the total volume of issuance. The trend of the rolling annual earnings per share for Microbot Medical Inc. (MBOT) reflects profit sensitivity to the development costs of surgical robots, where future growth of this metric will be driven by high-margin sales of disposable instruments to hospitals.